Besides, we found that obesity interferes with the immune microenvironment of OSCC by recruiting MDSCs via the CCL9-CCR1 axis, highlighting the potential therapeutic value of targeting MDSCs and blocking CCL9-CCR1 axis in this context. The gene discussed is CCR1; the disease is Obesity.